PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 2, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 02, 2026 AFC-HD AMS Life Science Co., Ltd. [2927.T] TOKYO, Feb 02 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (2927.T) reported the monthly exercise status of its sixth tranche warrant (exercise price adjustment clause attached) issued to EVO FUND in January 2026. In January, 950 warrants were exercised, resulting in the issuance of 95,000 shares. As of December 31, 2025, there were 1,400 unexercised warrants remaining, equivalent to 45,000 share